comparemela.com

Latest Breaking News On - Elizabetho day - Page 1 : comparemela.com

Olaris, Inc debuts novel global QqQ LC mass spectrometry panel for clinical metabolomics applications at the American Society for Mass Spectrometry 2023 Meeting

Framingham, MA (PRWEB) June 05, 2023 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning to discover and develop its

United statesJurre kamphorstPolaris incAmerican society for mass spectrometryIms technologyAmerican societyMass spectrometryElizabetho dayComprehensive early responsive evaluationBiomarkers relatedPress release

Olaris, Inc to present data on metabolomic changes observed during DCD heart perfusion prior to successful transplant at the American Transplant Congress 2023 Meeting

Framingham, MA (PRWEB) June 05, 2023 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning to discover and develop its

United statesSan diegoSeyed alireza rabiAsishana oshoDavid dalessandroAmerican transplant congressPolaris incCirculatory deathMassachusetts general hospitalDavidd alessandroSurgical directorHeart transplantationVentricular assist devicesElizabetho dayComprehensive early responsive evaluationBiomarkers related

Olaris Grows Leadership Team with Appointment of Dr Stuart Chaffee as Executive Chairman

Framingham, MA (PRWEB) September 26, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery and

Stuart chaffeeYale universityPolaris incCollege of williamAffinivax incAtlas ventureWharton schoolUniversity of pennsylvaniaElizabetho dayChief business officerChief financial officerPraxis precision medicinesBusiness operationsKymera therapeuticsSynthetic organic chemistryChief executive officer

Olaris, Inc to present novel myOLARIS™-KTdx assay detecting graft status in kidney transplant recipients at American Transplant Congress 2022 Meeting

Framingham, Massachusetts (PRWEB) June 06, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery

United statesDirk kuypersPolaris incLaboratory of nephrologyAmerican transplant congressUniversity of leuvenInternational transplant scienceElizabetho dayComprehensive early responsive evaluationBiomarkers relatedPress release

Olaris, Inc to present non-invasive metabolic signature to detect over-immunosuppression in kidney transplant patients at International Transplant Science 2022 Meeting

Framingham, MA (PRWEB) May 12, 2022 Olaris, Inc, a precision medicine company leveraging metabolomics and machine learning for the discovery and

Dirk kuypersPolaris incLaboratory of nephrologyUniversity of leuvenInternational transplant scienceElizabetho dayComprehensive early responsive evaluationBiomarkers relatedPress release

vimarsana © 2020. All Rights Reserved.